Literature DB >> 32382394

Plasmablastic lymphoma as a manifestation of the human immunodeficiency virus: Case report.

Gonzalo Vera1, Pablo Cordova2,3, Gerson Sepulveda3, Tatiana Benavides3, Felipe Astorga3, Wilfredo Gonzalez3,4.   

Abstract

Plasmablastic lymphoma is a rare subtype of non-Hodgkin's lymphoma, which generally presents an aggressive clinical course and low survival rates. It is strongly associated with HIV infection and the most common site of involvement of the territory of the head and neck is Waldeyer's lymphatic ring, followed by the gastrointestinal tract, lymph nodes and skin. The morphological characteristics of PBL in the oral cavity / jaw in the context of HIV infection show diffuse sheets of large immunoblastic cells with abundant cytoplasm, vesicular chromatin and prominent nucleus, a small located in the center with plasma cells differentiation. The main goal of this article is to review the literature of the plasmablastic lymphoma and report a case. Key words:Plasmablastic lymphoma, PBL, HIV, AIDS, Non Hodgkin Lynphoma. Copyright:
© 2020 Medicina Oral S.L.

Entities:  

Year:  2020        PMID: 32382394      PMCID: PMC7195680          DOI: 10.4317/jced.56482

Source DB:  PubMed          Journal:  J Clin Exp Dent        ISSN: 1989-5488


  15 in total

1.  Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma.

Authors:  Janice S Ahn; Ryan Okal; Jeffrey A Vos; Matthew Smolkin; Abraham S Kanate; Flavia G Rosado
Journal:  J Clin Pathol       Date:  2017-03-01       Impact factor: 3.411

Review 2.  Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point.

Authors:  Ebru Linke-Serinsöz; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Semin Diagn Pathol       Date:  2017-04-07       Impact factor: 3.464

Review 3.  The biology and treatment of plasmablastic lymphoma.

Authors:  Jorge J Castillo; Michele Bibas; Roberto N Miranda
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

4.  Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.

Authors:  Yusuke Koizumi; Tomoko Uehira; Yasunori Ota; Yoshihiko Ogawa; Keishiro Yajima; Junko Tanuma; Mihoko Yotsumoto; Shotaro Hagiwara; Satoshi Ikegaya; Dai Watanabe; Hitoshi Minamiguchi; Keiko Hodohara; Kenta Murotani; Hiroshige Mikamo; Hideho Wada; Atsushi Ajisawa; Takuma Shirasaka; Hirokazu Nagai; Yoshinori Kodama; Tsunekazu Hishima; Makoto Mochizuki; Harutaka Katano; Seiji Okada
Journal:  Int J Hematol       Date:  2016-09-07       Impact factor: 2.490

5.  Plasmablastic lymphoma may occur as a high-grade transformation from plasmacytoma.

Authors:  Xin Qing; Nora Sun; Elena Chang; Samuel French; Ping Ji; Changjun Yue
Journal:  Exp Mol Pathol       Date:  2010-10-19       Impact factor: 3.362

6.  Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.

Authors:  Francisco Vega; Chung-Che Chang; Leonard J Medeiros; Mark M Udden; Jeong Hee Cho-Vega; Ching-Ching Lau; Chris J Finch; Regis A Vilchez; David McGregor; Jeffrey L Jorgensen
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

Review 7.  Plasmablastic lymphoma: a review.

Authors:  P Rafaniello Raviele; G Pruneri; E Maiorano
Journal:  Oral Dis       Date:  2008-10-07       Impact factor: 3.511

8.  Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.

Authors:  Ghaleb Elyamany; Ali Matar Alzahrani; Muna Aljuboury; Najlah Mogadem; Nagham Rehan; Omar Alsuhaibani; Abdulaziz Alabdulaaly; Eman Al-Mussaed; Imad Elhag; Abdullah AlFiaar
Journal:  Diagn Pathol       Date:  2015-06-25       Impact factor: 2.644

Review 9.  Plasmablastic lymphoma: a systematic review.

Authors:  Jorge J Castillo; John L Reagan
Journal:  ScientificWorldJournal       Date:  2011-03-22

10.  An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature Review.

Authors:  Marcelo Corti; Gonzalo Minué; Ana Campitelli; Marina Narbaitz; Leonardo Gilardi
Journal:  Int Arch Otorhinolaryngol       Date:  2015-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.